In this episode, our guest is Sarah Arington Leach, who currently serves as VP of Strategic Commercialization at Prasco. Her primary objective is to provide pharmaceutical manufacturers with solutions that break down barriers of entry and create access for needed and innovative therapies for patients and caregivers. Prior to Prasco, she worked at OhioHealth implementing 340B and Own-Use programs. Her passion was ignited for serving patients during her time spent in both the inpatient and ambulatory pharmacy settings. She is the granddaughter of Prasco’s Founder & Chairman, E. Thomas Arington and the daughter of Christopher H. Arington, the company’s Vice-Chairman & CEO. Prasco is committed to honoring God and His greatest commandment summarized by the phrase “love God and love people”.

Sarah completed her undergraduate degrees in Economics and Spanish at Emory University and received her MBA from Xavier University. 

Interview topics: 

• Prasco (who we are, what we do, our culture)
  • Pharmaceutical Research Science Christian Outreach
  • Different components of the business:
    • Virtual manufacturing
    • 3D printing
• Market trends and changes and the impact to both brand and generic manufacturers
• Commercializing products
  • Launched 19 blockbuster drugs ($1B); high service level
  • 22 AGs; Flovent was discontinued
• Drug shortages
  • 40% of generic approvals don’t make it to market

Guest - Sarah Arington Leach, MBA: https://www.linkedin.com/in/sarah-arington-leach-aa2666b3/

Host - Hillary Blackburn, PharmD, MBA

• www.hillaryblackburn.com  
• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook
• @HillBlackburn Twitter